Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-11-10

Clinical Trial Update: Study of Patient Use and Perception of the Travatan Dosing Aid [Phase 4]

View source ↗

Summary

A completed Phase 4 study sponsored by Wills Eye assessed how patients used and perceived the Travatan Dosing Aid in glaucoma management.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Travatan (travoprost)

Snippet

Sponsor: Wills Eye | Conditions: Glaucoma | Phase 4 | Status: COMPLETED